BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 28096355)

  • 1. A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity.
    Perni M; Galvagnion C; Maltsev A; Meisl G; Müller MB; Challa PK; Kirkegaard JB; Flagmeier P; Cohen SI; Cascella R; Chen SW; Limbocker R; Sormanni P; Heller GT; Aprile FA; Cremades N; Cecchi C; Chiti F; Nollen EA; Knowles TP; Vendruscolo M; Bax A; Zasloff M; Dobson CM
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E1009-E1017. PubMed ID: 28096355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine.
    Perni M; Flagmeier P; Limbocker R; Cascella R; Aprile FA; Galvagnion C; Heller GT; Meisl G; Chen SW; Kumita JR; Challa PK; Kirkegaard JB; Cohen SIA; Mannini B; Barbut D; Nollen EAA; Cecchi C; Cremades N; Knowles TPJ; Chiti F; Zasloff M; Vendruscolo M; Dobson CM
    ACS Chem Biol; 2018 Aug; 13(8):2308-2319. PubMed ID: 29953201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces.
    Brown JW; Buell AK; Michaels TC; Meisl G; Carozza J; Flagmeier P; Vendruscolo M; Knowles TP; Dobson CM; Galvagnion C
    Sci Rep; 2016 Nov; 6():36010. PubMed ID: 27808107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.
    Galvagnion C
    J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
    Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
    Sahay S; Ghosh D; Singh PK; Maji SK
    Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease.
    Hideshima M; Kimura Y; Aguirre C; Kakuda K; Takeuchi T; Choong CJ; Doi J; Nabekura K; Yamaguchi K; Nakajima K; Baba K; Nagano S; Goto Y; Nagai Y; Mochizuki H; Ikenaka K
    Sci Rep; 2022 Jan; 12(1):351. PubMed ID: 35013421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of α-synuclein aggregation within liquid condensates.
    Dada ST; Toprakcioglu Z; Cali MP; Röntgen A; Hardenberg MC; Morris OM; Mrugalla LK; Knowles TPJ; Vendruscolo M
    Nat Commun; 2024 May; 15(1):3835. PubMed ID: 38714700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexation of NAC-Derived Peptide Ligands with the C-Terminus of α-Synuclein Accelerates Its Aggregation.
    Jha NN; Ranganathan S; Kumar R; Mehra S; Panigrahi R; Navalkar A; Ghosh D; Kumar A; Padinhateeri R; Maji SK
    Biochemistry; 2018 Feb; 57(5):791-804. PubMed ID: 29286644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid vesicles affect the aggregation of 4-hydroxy-2-nonenal-modified α-synuclein oligomers.
    Sardar Sinha M; Villamil Giraldo AM; Öllinger K; Hallbeck M; Civitelli L
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3060-3068. PubMed ID: 29960040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3.
    Fukui N; Yamamoto H; Miyabe M; Aoyama Y; Hongo K; Mizobata T; Kawahata I; Yabuki Y; Shinoda Y; Fukunaga K; Kawata Y
    J Biol Chem; 2021; 296():100663. PubMed ID: 33862084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental mechanisms of amyloid fibril formation by alpha-synuclein in Parkinson's disease: quantitative modelling].
    Galvagnion C; Buell AK
    Med Sci (Paris); 2015; 31(6-7):597-600. PubMed ID: 26152159
    [No Abstract]   [Full Text] [Related]  

  • 13. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.
    Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein.
    Ahsan N; Mishra S; Jain MK; Surolia A; Gupta S
    Sci Rep; 2015 May; 5():9862. PubMed ID: 25985292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling amyloid formation paths of Parkinson's disease protein α-synuclein triggered by anionic vesicles.
    Kiskis J; Horvath I; Wittung-Stafshede P; Rocha S
    Q Rev Biophys; 2017 Jan; 50():e3. PubMed ID: 29233215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-Synuclein Proximity Ligation Assay (AS-PLA) in Brain Sections to Probe for Alpha-Synuclein Oligomers.
    Roberts RF; Bengoa-Vergniory N; Alegre-Abarrategui J
    Methods Mol Biol; 2019; 1948():69-76. PubMed ID: 30771171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into the molecular mechanism underlying the inhibition of α-synuclein aggregation by hydroxytyrosol.
    Palazzi L; Leri M; Cesaro S; Stefani M; Bucciantini M; Polverino de Laureto P
    Biochem Pharmacol; 2020 Mar; 173():113722. PubMed ID: 31756328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein mimetic 2D FAST rescues alpha synuclein aggregation mediated early and post disease Parkinson's phenotypes.
    Stillman NH; Joseph JA; Ahmed J; Baysah CZ; Dohoney RA; Ball TD; Thomas AG; Fitch TC; Donnelly CM; Kumar S
    Nat Commun; 2024 Apr; 15(1):3658. PubMed ID: 38688913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC.
    Palazzi L; Fongaro B; Leri M; Acquasaliente L; Stefani M; Bucciantini M; Polverino de Laureto P
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olive oil tyrosols reduce α-synuclein aggregation
    Hernández-García S; García-Cano B; Martínez-Rodríguez P; Henarejos-Escudero P; Gandía-Herrero F
    Food Funct; 2024 Jul; 15(13):7214-7223. PubMed ID: 38817211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.